Drug Approval | October 21, 2021
U.S. FDA gives green light to Moderna and J&J booster doses
The authority also allowed mix and match of booster doses once the primary vaccine has been administered.
The authority also allowed mix and match of booster doses once the primary vaccine has been administered.
The Amplitude Solution gives laboratories the ability to scale Covid-19 PCR testing and process up to 8,000 samples a day
U.S. FDA to decide whether to authorize a booster dose in the coming days
_256_384.jpg)
It works by collecting aerosols and identifies the presence of dangerous pathogens using sensitive, specific and rapid detection in near-real time without laboratory analysis
This new lyophilizer is equipped with systems to best protect high value Active Pharmaceutical Ingredients (APIs) and doubles the lyophilization capacity at the site
_256_384.jpg)
The two doses of Covaxin are likely to be administered to children with a gap of 28 days
AZD7442 reduced risk of developing severe Covid-19 or death in Tackle Phase III outpatient treatment trial
It recommends using the vaccine to prevent the spread of the disease
Early-stage research suggests the potential to prevent and treat all dengue serotypes and builds on Johnson & Johnson's work to advance science against emerging and entrenched global public health threats
A growing number of studies have shown the benefit of a third dose of Covid-19 vaccine in immunocompromised subjects
Subscribe To Our Newsletter & Stay Updated
